# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-093285
Filing Date
2024-08-08
Accepted
2024-08-08 06:46:28
Documents
52
Period of Report
2024-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | nuvl-20240630.htm iXBRL | 10-Q | 2037236
2 | EX-31.1 | nuvl-ex31_1.htm | EX-31.1 | 16231
3 | EX-31.2 | nuvl-ex31_2.htm | EX-31.2 | 16240
4 | EX-32.1 | nuvl-ex32_1.htm | EX-32.1 | 9486
5 | EX-32.2 | nuvl-ex32_2.htm | EX-32.2 | 8256
6 | GRAPHIC | img240556275_0.jpg | GRAPHIC | 173738
| Complete submission text file | 0000950170-24-093285.txt |  | 6424608

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | nuvl-20240630.xsd | EX-101.SCH | 745836
55 | EXTRACTED XBRL INSTANCE DOCUMENT | nuvl-20240630_htm.xml | XML | 820779

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40671 | Film No.: 241185912
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)